Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

Voyager seeks relaxed requirements in NASA commercial space station RFP

WASHINGTON — Voyager Technologies remains upbeat about the prospects for its Starlab commercial space station but is hoping for some tweaks to NASA’s plans to support the station’s development.

During an Aug. 4 earnings call about the company’s second-quarter financial results, Voyager executives emphasized the strong commercial demand for Starlab, with more than $500 million in agreements in place to use the station.

“This demonstrates that Starlab has progressed well beyond a development concept and is already attracting meaningful government and commercial commitment,” said Phil de Sousa, Voyager’s chief financial officer.

LIVE SpaceX Rocket Crashing Into The Moon | Falcon 9 Upper Stage Crash LIVE Tracking

LIVE TRACKING: Watch the SpaceX Falcon 9 Upper Stage as it approaches its final impact with the Moon.

This livestream features:

Live Moon Animation.
Telescope Feed (when available)
Real-Time Impact Countdown.
Live Distance & Speed Tracking.
Predicted Impact Near Einstein Crater.
Falcon 9 Upper Stage Telemetry.
Mission Control Dashboard.

Mission Details.

Object: Falcon 9 Upper Stage.
Estimated Mass: 3,900 kg.
Speed: 2.43 km/s (≈8,700 km/h)
Target: Near Einstein Crater.
Event Type: Uncontrolled Artificial Lunar Impact.
Earth Risk: None.

This historic event gives scientists a rare opportunity to study an artificial impact on the lunar surface and the resulting ejecta plume.

DHS Science & Technology Directorate Is a Strategic Asset

Chuck Brooks is the president of Brooks Consulting International and one of Executive Mosaic’s GovCon Experts.

Most people associate the Department of Homeland Security with disaster relief, cybersecurity activities, border security, airport security, or the Coast Guard. Few people are aware of the Department of Homeland Security’s Science & Technology Directorate, or DHS S&T, which quietly fosters the innovation behind many of those missions.

I consider the Science & Technology Directorate to be one of America’s most significant—yet frequently overlooked—strategic assets. I do have a bias because I was involved in the creation of the Directorate DHS during its early years serving as it first Director of Legislative Affairs and have closely followed its continued development through my work in government, academia and industry.

IL-1 pathway may stop Candida fungus from turning fatal in weakened immunity

An immune pathway has been discovered that prevents a normally harmless fungus from developing into a fatal infection. The King’s College London study, published in Nature Microbiology, provides the first potential clue as to why only certain patients with weakened immune systems, including those undergoing chemotherapy or living with HIV, are at risk of life-threatening Candida albicans infections.

Candida albicans is a fungus that normally lives harmlessly in areas such as the mouth and gut but can sometimes spread through the body and cause fatal disease.

If the results are confirmed in humans, they could provide a test to identify who is at risk of developing fatal fungal infections and represent a potential therapeutic target to reduce the risk of developing the disease.

Reversal of protein chemical aging by enzymatic deglycation

et al. used an innovative series of screening and directed evolution steps to produce a new enzyme (CMLase) which can remove a pernicious form of advanced glycation end product (AGE) linkage from proteins. AGEs contribute to biological aging, so CMLase may possess therapeutic potential to combat parts of the aging process.


Advanced glycation end products (AGEs) in proteins, a hallmark of aging, are considered irreversible. Here, authors report the development of CMLase — an enzyme that specifically oxidizes Nε-carboxymethyl-lysine (CML) and restores the native lysine residues in vitro and in human tissue samples.

DeepSeek’s new AI model is by far the cheapest of wellknown models to run, research firm says

A version of Chinese startup DeepSeek’s flagship AI model is by ‌far the least expensive to run on benchmark tests among well-known models globally and more than 100 times cheaper to run than Anthropic’s Claude Fable 5, according to a research firm.

/* */